Cornelia Dorner‐Ciossek

Targeted Antioxidative and Neuroprotective Properties of the Dopamine Agonist Pramipexole and Its Nondopaminergic Enantiomer SND919CL2x [(+)2-Amino-4,5,6,7-tetrahydro-6-lpropylamino-benzathiazole Dihydrochloride]

Ruth Danzeisen, B. Schwalenstoecker, Frank Gillardon et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 104 citations

PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition

Katja S. Kroker, Chantal Mathis, Anelise Marti et al. · Neurobiology of Aging · 2014 · 63 citations

Synaptic Plasticity, Alzheimer's Disease, Beta-induced Deficits +9

Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP

Katja S. Kroker, Georg Rast, Riccardo Giovannini et al. · Neuropharmacology · 2012 · 59 citations

Differential Effects, Alzheimer's Disease, Neurophysiology +9

A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology

Niklas Schuelert, Cornelia Dorner‐Ciossek, Michael Brendel et al. · Physiological Reports · 2018 · 58 citations · Full text

Neuropsychology, Neurotransmitter, Neurophysiological Biomarkers +30

Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disorders

Joseph Scarborough, Flavia S. Mueller, Roberto Arban et al. · Brain Behavior and Immunity · 2020 · 57 citations · Full text